EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection






International Journal of Std & Aids 5(5): 353-355

The use of intravenous pentamidine as prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection

Eight men with multiple drug reactions used intravenous (i.v.) pentamidine as Pneumocystis prophylaxis. Seven had AIDS before starting pentamidine treatment and the eighth had advanced symptomatic HIV disease. Each patient received a monthly i.v. infusion of pentamidine at a dose of 4 mg/kg over 1 h. Three of the 8 patients developed P. carinii pneumonia while taking pentamidine, but compliance was poor.

(PDF same-day service: $19.90)

Accession: 002530388

PMID: 7819354

DOI: 10.1177/095646249400500513



Related references

Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection. Pediatric Pulmonology. Supplement 16: 199-200, 1997

Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients. Pediatric Transplantation 19(3): 326-331, 2015

Use of intravenous pentamidine as prophylaxis of pneumocystis carinii pneumonia. Viii International Conference on Aids And The Iii Std World Congress Published Abstracts Submitted to The Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, 220p Viii International Congress And The Iii Std World Congress: Amsterdam, Netherlands Paper : 55, 1992

Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia. Clinical Infectious Diseases 18(6): 901-904, 1994

Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia. Journal of Pediatrics 122(1): 163-164, 1993

Secondary prophylaxis of Pneumocystis carinii pneumonia with intravenous pentamidine. Medicina Clinica Barcelona 95(5): 197-198, 1990

HIV-associated Pneumocystis carinii pneumonia, primary pentamidine inhalation prophylaxis notwithstanding. Are there differences with Pneumocystis carinii pneumonia without prophylaxis?. Deutsche Medizinische Wochenschrift 121(4): 83-89, 1996

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. AIDS Forschung 8(4): 177-178, 1993

Primary and secondary prophylaxis of Pneumocystis carinii pneumonia with pentamidine aerosol. Efficacy, side effects and frequency of extrapulmonary Pneumocystis carinii manifestation. Medizinische Klinik 89(3): 132-135, 1994

Risk factors for prophylaxis failure in patients receiving aerosol pentamidine for Pneumocystis carinii pneumonia prophylaxis. Chest 119(5): 1427-1433, 2001